Ocugen Inc (OCGN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $262.28M
Last updated: Nov 17, 2026 at 4:42 PM ET
Ocugen Inc (OCGN) Stock Chart
Ocugen (OCGN) has a latest price of $0.76 on Nov 17, 2026, 72.2% below its 52-week high of $2.73. Its price fell 36.4% over the past 12 months. The month-end price fell 99.6% over the 10 years through Oct 2026, a compound annual decline of 41.9%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $174.85 in Aug 2018 and its lowest $0.22 in Jun 2020, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart OCGN with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for OCGN.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 48.9%, and over 6 months it fell 41.8%. The month-end price rose 91.0% over the 3 years through Oct 2026, a compound annual rate of 24.1%.
| Period | Change |
|---|---|
| 1 month | -3.9% |
| 3 months | -48.9% |
| 6 months | -41.8% |
| 12 months | -36.4% |
| 12 months, with dividends | -36.4% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +91.0% | +24.1% |
| 5 years | -94.1% | -43.2% |
| 10 years | -99.6% | -41.9% |
Price by Year
Its best calendar year was 2020, when the price rose 251.9%, and its weakest was 2018, when it fell 95.7%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.70 | -47.9% |
| 2025 | $1.35 | +67.7% |
| 2024 | $0.81 | +40.0% |
| 2023 | $0.57 | -55.8% |
| 2022 | $1.30 | -71.4% |
| 2021 | $4.55 | +148.6% |
| 2020 | $1.83 | +251.9% |
| 2019 | $0.52 | -90.2% |
| 2018 | $5.29 | -95.7% |
| 2017 | $122.75 | +22.8% |
Trading Range
The price is 17.1% below its 50-day average of $0.91 and 45.3% below its 200-day average of $1.38.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.76 | |
| 52-week high | $2.73 | -72.2% |
| 52-week low | $0.69 | +9.5% |
| 50-day average | $0.91 | -17.1% |
| 200-day average | $1.38 | -45.3% |
Price Risk
Over 3 years, its largest fall from a peak was 73.9%.
| Measure | Value |
|---|---|
| 1-year beta | 1.76 |
| Largest fall, 1 year | -71.7% |
| Largest fall, 3 years | -73.9% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About OCGN
What is OCGN's 1-year price change?
Ocugen's price fell 36.4% over the past 12 months. With dividends included, the 12-month total return was -36.4%.
What is OCGN's 5-year price change?
Ocugen's month-end price fell 94.1% over the 5 years through Oct 2026, a compound annual decline of 43.2%. These figures leave out dividends.
What is OCGN's 52-week high and low?
Ocugen's 52-week high is $2.73 and its 52-week low is $0.69. Its latest price of $0.76 on Nov 17, 2026 is 72.2% below the high.
What is OCGN's beta?
Ocugen's 1-year beta against the S&P 500 is 1.76, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 71.7%.
Is the OCGN chart free?
Yes. Advanced Charting for OCGN is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
OCGN pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors